PRAX
Praxis Precision Medicines Inc

1,611
Mkt Cap
$4.73B
Volume
2.49M
52W High
$206.71
52W Low
$26.70
PE Ratio
-14.67
PRAX Fundamentals
Price
$164.09
Prev Close
$189.32
Open
$191.00
50D MA
$115.97
Beta
0.50
Avg. Volume
1.32M
EPS (Annual)
-$10.21
P/B
11.67
Rev/Employee
$73,732.76
Loading...
Loading...
News
all
press releases
Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position
The firm alleged that Praxis “gamed” the data from its late-stage trial of Ulixacaltamide in essential tremor.
Stocktwits·5h ago
News Placeholder
More News
News Placeholder
HC Wainwright Issues Optimistic Estimate for PRAX Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Investment analysts at HC Wainwright boosted their FY2025 EPS estimates for Praxis Precision Medicines in a report issued on Thursday...
MarketBeat·4d ago
News Placeholder
HC Wainwright Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) Stock
HC Wainwright increased their target price on Praxis Precision Medicines from $232.00 to $258.00 and gave the company a "buy" rating in a research note on Thursday...
MarketBeat·6d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 7.2% - Here's Why
Praxis Precision Medicines (NASDAQ:PRAX) Shares Up 7.2% - Should You Buy...
MarketBeat·8d ago
News Placeholder
Research Analysts Offer Predictions for PRAX FY2025 Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Research analysts at Lifesci Capital raised their FY2025 earnings per share (EPS) estimates for shares of Praxis Precision Medicines in...
MarketBeat·11d ago
News Placeholder
What is Wedbush's Forecast for PRAX FY2025 Earnings?
Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Wedbush lifted their FY2025 earnings estimates for Praxis Precision Medicines in a report issued on Thursday, November 6th. Wedbush...
MarketBeat·11d ago
News Placeholder
Wedbush Raises Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $77.00
Wedbush increased their price target on Praxis Precision Medicines from $73.00 to $77.00 and gave the company an "underperform" rating in a report on Thursday...
MarketBeat·13d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 8.5% - Time to Sell?
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 8.5% - What's Next...
MarketBeat·14d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS
Praxis Precision Medicines (NASDAQ:PRAX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($3.36) earnings per share (EPS) for the quarter, beating the...
MarketBeat·14d ago
News Placeholder
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy?
Praxis Precision Medicines (PRAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·22d ago

Latest PRAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.